Published in

Wiley, Pediatric Blood & Cancer, 3(65), p. e26887

DOI: 10.1002/pbc.26887

Links

Tools

Export citation

Search in Google Scholar

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO